Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
---|---|---|---|---|
Tirono M | 2022 | intact cell/cell culture, <i>Lactobacillus acidophilus</i> | magnetic field, low frequency, 50/60 Hz | - |
Ye AF et al. | 2022 | intact cell/cell culture, human amniotic epithelial cells (FL) | magnetic field, 50/60 Hz, low frequency | - |
Moraveji M et al. | 2021 | intact cell/cell culture, rat adipose-derived mesenchymal stem cells | magnetic field, 50/60 Hz, signals/pulses, also other exposures without EMF, co-exposure | - |
Woroszyło M et al. | 2021 | bacterium | magnetic field, 50/60 Hz, low frequency | - |
Woroszyło M et al. | 2021 | bacterium, <i>Staphylococcus aureus</i> | magnetic field, low frequency, 50/60 Hz, also other exposures without EMF, co-exposure | 8.1–8.5 mT |
Chen L et al. | 2021 | intact cell/cell culture, human amniotic (FL) cells | magnetic field, 50/60 Hz, also other exposures without EMF, co-exposure | 0.2–0.4 mT |
Salek F et al. | 2021 | intact cell/cell culture | magnetic field, 50/60 Hz, co-exposure, also other exposures without EMF | 2.5 mT |
Colciago A et al. | 2021 | intact cell/cell culture, HEI-193 cells (human vestibular schwannoma cell line derived from a NF2 patient) | 50/60 Hz, magnetic field | 0.1 T |
Dong Y et al. | 2021 | intact cell/cell culture | magnetic field, signals/pulses, 50/60 Hz, also other exposures without EMF, co-exposure | - |
Bai W et al. | 2021 | intact cell/cell culture, neural stem cells from rat | 50/60 Hz, magnetic field | 5 mT–2.5 T |
Zhou J et al. | 2021 | intact cell/cell culture, newborn rat calvarial osteoblasts, animal, rat/Wistar | magnetic field, 50/60 Hz, low frequency | 1.8 mT |
Anaya M et al. | 2021 | intact cell/cell culture, fungal strains (<i>Aspergillus niger</i> Tiegh., <i>Penicillium citrinum</i> Thom., <i>Cladosporium cladosporioides</i> Fresen.) | 50/60 Hz, magnetic field | 1–5 mT |
Domínguez G et al. | 2021 | intact cell/cell culture, MDCK cells (Madin-Darby canine kidney cell line) | magnetic field, 50/60 Hz | 1–5 mT |
Asadian N et al. | 2021 | intact cell/cell culture, rat bone marrow-derived mesenchymal stem cells | 50/60 Hz, magnetic field | 400 µT |
Gao Q et al. | 2021 | animal, rat/Sprague Dawley (focal ischemia model), whole body | magnetic field, 50/60 Hz | 1 mT |
Consales C et al. | 2021 | intact cell/cell culture, SH-SY5Y (human neuroblastoma cell line) | magnetic field, 50/60 Hz | 1 mT |
Wu J et al. | 2021 | bacterium, composting material including bacteria | magnetic field, 50/60 Hz | - |
Lekovic MH et al. | 2020 | intact cell/cell culture, MRC-5 (human diploid fibroblasts) | 50/60 Hz, magnetic field | 10 mT |
Naghibzadeh M et al. | 2020 | intact cell/cell culture, human dermal fibroblasts | magnetic field, 50/60 Hz | 1–5 mT |
Xu A et al. | 2020 | - | magnetic field, 50/60 Hz, low frequency | - |
Samiei M et al. | 2020 | intact cell/cell culture, human dental pulp stem cells | magnetic field, 50/60 Hz | 0.5–1 mT |
Chen L et al. | 2020 | - | magnetic field, 50/60 Hz | - |
Yuan LQ et al. | 2020 | intact cell/cell culture, human nephroblastoma cell line G401, human embryonic renal epithelial cell line HEK293, human lung cancer cell line A549, human bronchial epithelial cell line BEAS-2B, human gastric cancer cell line SGC-7901, human gastric epithelial cell line GES-1, human pancreatic cancer cell line PANC-1, human pancreatic ductal epithelial cell line HPDE6-C7, wild-type (WT) mouse embryonic fibroblast (MEF) cells, NBS1-/-MEF and MDC1-/-MEF cells | static magnetic field, magnetic field, 50/60 Hz, co-exposure | - |
Shapourzadeh A et al. | 2020 | intact cell/cell culture, adipose-derived stem cells | magnetic field, 50/60 Hz, co-exposure, also other exposures without EMF | 31.4–62.8 µT |
Escobar JF et al. | 2020 | - | magnetic field, 50/60 Hz | - |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.